Three exceptional young clinicians with novel approaches to fighting cancer have been named the 2025 recipients of the Damon Runyon Physician-Scientist Training Award.

New study finds that war has a profound and lasting impact on civilian sleep, even among those not directly exposed to combat. Across four large-scale studies, researchers found sharp increases in insomnia, short sleep duration, and reliance on sleep medication among the Israeli population during the 2023–2024 Israel–Hamas war. These sleep disruptions persisted even six months into the conflict, despite a decrease in reported psychological distress—suggesting that the effects on sleep are not just immediate reactions to acute stress, but may represent longer-term consequences of living under sustained threat. The study also identified particularly vulnerable groups, including women and individuals with higher exposure to trauma, who experienced more severe sleep impairments. These findings underscore the importance of recognizing sleep as a critical component of civilian health during times of war and ensuring that it is addressed in both emergency and long-term public health strategies.

The stress health care workers such as certified nursing assistants face can be overwhelming. New research from the University of Georgia suggests that helping CNAs with career advancement opportunities could stop them from quitting.

A study from Catholic University, Piacenza, on the forever chemicals that threaten the human and planet health

Cambridge, MA, June 16 — Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the close of its Series E financing round at a total of around $123 million, surpassing its initial target amid strong investor interest. The oversubscribed series E round further recognizes Insilico’s unique dual-engine business model, which combines a generative AI platform with deep in-house drug discovery capabilities to continuously enhance reinforcement learning, strengthen Pharma.AI, and drive scientific innovation.